bioAffinity Technologies, Inc. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- bioAffinity Technologies, Inc. stock issued during period, value, other for the quarter ending 2026-06-30 was $3.20M, a 1220.52% increase year-over-year.
- bioAffinity Technologies, Inc. stock issued during period, value, other for the quarter ending 2025-12-31 was $1.80M, a 32.40% decline year-over-year.
- bioAffinity Technologies, Inc. stock issued during period, value, other for the quarter ending 2025-09-30 was $6.09M, a 1252.84% increase year-over-year.
- bioAffinity Technologies, Inc. stock issued during period, value, other for the quarter ending 2025-06-30 was $242.33K.
- bioAffinity Technologies, Inc. stock issued during period, value, other for fiscal 2025 was $8.13M, a 44.85% increase from fiscal 2024.
- bioAffinity Technologies, Inc. stock issued during period, value, other for fiscal 2024 was $5.61M.
- bioAffinity Technologies, Inc. stock issued during period, value, other for fiscal 2022 was $16.07M.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2026-06-30 | $3.20M 10-Q · filed 2026-08-07 | |
| 2025-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $8.13M 10-K · filed 2026-03-16 |
| 2025-09-30 | $6.09M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $242.33K 10-Q · filed 2026-08-07 | |
| 2024-12-31 | $2.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $5.61M 10-K · filed 2026-03-16 |
| 2024-09-30 | $450.00K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | |
| 2024-03-31 | $2.50M 10-Q · filed 2025-05-15 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $16.07M 10-K · filed 2024-04-01 |
| 2022-09-30 | $16.07M 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |